288 related articles for article (PubMed ID: 19004835)
1. Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses.
Isenberg JS; Annis DS; Pendrak ML; Ptaszynska M; Frazier WA; Mosher DF; Roberts DD
J Biol Chem; 2009 Jan; 284(2):1116-25. PubMed ID: 19004835
[TBL] [Abstract][Full Text] [Related]
2. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1.
Isenberg JS; Ridnour LA; Dimitry J; Frazier WA; Wink DA; Roberts DD
J Biol Chem; 2006 Sep; 281(36):26069-80. PubMed ID: 16835222
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation.
Isenberg JS; Shiva S; Gladwin M
Nitric Oxide; 2009 Aug; 21(1):52-62. PubMed ID: 19481167
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP.
Yao M; Roberts DD; Isenberg JS
Pharmacol Res; 2011 Jan; 63(1):13-22. PubMed ID: 20971192
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury.
Isenberg JS; Maxhimer JB; Hyodo F; Pendrak ML; Ridnour LA; DeGraff WG; Tsokos M; Wink DA; Roberts DD
Am J Pathol; 2008 Oct; 173(4):1100-12. PubMed ID: 18787106
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress.
Isenberg JS; Qin Y; Maxhimer JB; Sipes JM; Despres D; Schnermann J; Frazier WA; Roberts DD
Matrix Biol; 2009 Mar; 28(2):110-9. PubMed ID: 19284971
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses.
Isenberg JS; Wink DA; Roberts DD
Cardiovasc Res; 2006 Sep; 71(4):785-93. PubMed ID: 16820142
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake.
Isenberg JS; Jia Y; Fukuyama J; Switzer CH; Wink DA; Roberts DD
J Biol Chem; 2007 May; 282(21):15404-15. PubMed ID: 17416590
[TBL] [Abstract][Full Text] [Related]
9. Blocking thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia.
Isenberg JS; Hyodo F; Pappan LK; Abu-Asab M; Tsokos M; Krishna MC; Frazier WA; Roberts DD
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2582-8. PubMed ID: 17916772
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling.
Isenberg JS; Romeo MJ; Yu C; Yu CK; Nghiem K; Monsale J; Rick ME; Wink DA; Frazier WA; Roberts DD
Blood; 2008 Jan; 111(2):613-23. PubMed ID: 17890448
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.
Kaur S; Martin-Manso G; Pendrak ML; Garfield SH; Isenberg JS; Roberts DD
J Biol Chem; 2010 Dec; 285(50):38923-32. PubMed ID: 20923780
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation.
Isenberg JS; Hyodo F; Matsumoto K; Romeo MJ; Abu-Asab M; Tsokos M; Kuppusamy P; Wink DA; Krishna MC; Roberts DD
Blood; 2007 Mar; 109(5):1945-52. PubMed ID: 17082319
[TBL] [Abstract][Full Text] [Related]
13. Age-associated induction of cell membrane CD47 limits basal and temperature-induced changes in cutaneous blood flow.
Rogers NM; Roberts DD; Isenberg JS
Ann Surg; 2013 Jul; 258(1):184-91. PubMed ID: 23275312
[TBL] [Abstract][Full Text] [Related]
14. Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling.
Isenberg JS; Frazier WA; Krishna MC; Wink DA; Roberts DD
Curr Drug Targets; 2008 Oct; 9(10):833-41. PubMed ID: 18855617
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent regulation of skeletal muscle mitochondria by the thrombospondin-1 receptor CD47.
Frazier EP; Isenberg JS; Shiva S; Zhao L; Schlesinger P; Dimitry J; Abu-Asab MS; Tsokos M; Roberts DD; Frazier WA
Matrix Biol; 2011 Mar; 30(2):154-61. PubMed ID: 21256215
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-1/CD47 blockade following ischemia-reperfusion injury is tissue protective.
Maxhimer JB; Shih HB; Isenberg JS; Miller TW; Roberts DD
Plast Reconstr Surg; 2009 Dec; 124(6):1880-1889. PubMed ID: 19952644
[TBL] [Abstract][Full Text] [Related]
17. Thrombospondin-1 activation of signal-regulatory protein-α stimulates reactive oxygen species production and promotes renal ischemia reperfusion injury.
Yao M; Rogers NM; Csányi G; Rodriguez AI; Ross MA; St Croix C; Knupp H; Novelli EM; Thomson AW; Pagano PJ; Isenberg JS
J Am Soc Nephrol; 2014 Jun; 25(6):1171-86. PubMed ID: 24511121
[TBL] [Abstract][Full Text] [Related]
18. Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease.
Isenberg JS; Romeo MJ; Maxhimer JB; Smedley J; Frazier WA; Roberts DD
Ann Surg; 2008 May; 247(5):860-8. PubMed ID: 18438125
[TBL] [Abstract][Full Text] [Related]
19. Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signaling.
Maxhimer JB; Soto-Pantoja DR; Ridnour LA; Shih HB; Degraff WG; Tsokos M; Wink DA; Isenberg JS; Roberts DD
Sci Transl Med; 2009 Oct; 1(3):3ra7. PubMed ID: 20161613
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-β inhibits No-cGMP signaling in a CD36- and CD47-dependent manner.
Miller TW; Isenberg JS; Shih HB; Wang Y; Roberts DD
PLoS One; 2010 Dec; 5(12):e15686. PubMed ID: 21203512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
